Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0470
-0.0060 (-11.32%)
Mar 26, 2026, 3:20 PM EST

PVCT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
202350404523
Market Cap Growth
-56.19%-53.45%25.33%-11.35%96.93%-1.55%
Enterprise Value
232653434823
Last Close Price
0.050.060.120.100.110.06
PS Ratio
59.5569.9081.7972.2145.94-
PB Ratio
-3.18-3.73-8.46-5.30-7.29-5.51
EV/Sales Ratio
67.6976.9486.0577.2548.64-
Debt / Equity Ratio
-0.47-0.47-0.53-0.40-0.35-0.42
Net Debt / Equity Ratio
-0.43-0.43-0.48-0.39-0.35-0.25
Net Debt / EBITDA Ratio
-0.51-0.51-0.73-1.18-0.76-0.23
Net Debt / FCF Ratio
-0.82-0.82-0.88-1.15-0.71-1.05
Asset Turnover
0.400.400.500.320.36-
Quick Ratio
0.040.040.040.010.000.09
Current Ratio
0.080.080.140.150.230.45
Return on Assets (ROA)
-388.46%-388.46%-200.92%-89.58%-64.62%-141.40%
Return on Capital Employed (ROCE)
85.40%85.40%66.10%33.00%46.60%110.80%
Earnings Yield
-27.14%-23.12%-9.44%-7.70%-7.82%-24.01%
FCF Yield
--14.16%-6.51%-6.39%-6.69%-4.39%
Buyback Yield / Dilution
-0.16%-0.11%-0.07%-0.01%-2.76%-3.81%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.